Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Ldl-Heart'
Ldl-Heart published presentations and documents on DocSlides.
Residual risk: Is LDL target enough?
by candy
An interpretation of the continuous relationship b...
PCSK9 Inhibition: LDL Lowering
by SweetiePie
PCSK9 inhibitors. New option for dyslipidemia. Ali...
LDL Apheresis in Drug Resistant Nephrotic Syndrome
by obrien
Rodney D Gilbert. Patient JM. 14 year old girl, pr...
Is lower better? LDL targets and beyond.
by olivia-moreira
Implications of the relationship between risk fac...
Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?
by min-jolicoeur
NICE –CG 181 Continuum of CVD Risk and its trea...
Is lower better? LDL targets and beyond.
by trish-goza
Implications of the relationship between risk fac...
Abnormalities of LDL metabolism
by briana-ranney
Physiology, pathophysiology and treatments. Under...
SWL lipid management guideline update- Highlights
by finley
. Pedro Bandeira. Specialist Pharmacist- Cardiov...
Dyslipidemia (Med-3) Dr Anwar A Jammah
by bety
, MD, FRCPC, FACP, CCD, ECNU.. Associate . Profess...
Fats Cholesterol Saturated Fats
by paige
Unsaturated Fats . Trans Fats . Fats. Help the bod...
Lipids and lipoproteins Lipid chemistry and cardiovascular profile
by cadie
Main lipids in the blood are the triglycerides and...
Cholesterol transport and uptake
by wilson
Dr. Carolyn K. Suzuki. 1. To compare and contrast ...
Update on Clinical Trials:
by adia
How Will This Affect Practice in the Future?. Pame...
in general it is present in the body in two types, the good "HDL" and the bad "LDL" cholesterol.
by mary
Cholestero. l. Cholesterol is a fatty substance ne...
Hyperlipidemia Done by: Mohannad A. AL-Shibani
by nicole
Pharm.D intern. 1. . Main points. Pathophsiology...
Hypolipidemic drugs Shaymaa F. Abbas
by norah
Pharmacology Department. 24 SLIDES. 1. Learning ob...
LIPOPROTEINS Because lipids are relatively insoluble in aqueous media,
by deena
They bind with . soluble . protein. complexes . c...
CardioMetabolic Wellness
by osullivan
Gary E. Foresman, MD. January 2019. What Is Middle...
1 Dr. Samuel Wainaina (
by iris
D.Pharm. , . Bpharm. , MSc ). O. utl. i. ne. Intro...
Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a me
by priscilla
ApoB. and other lipoproteins. Mendelian randomisa...
Non-obese rheumatoid arthritis patients
by valerie
withlow. low-density lipoprotein have higher coro...
In the Name of God Management
by genevieve
of. Dyslipidemia. Navid Saadat, MD. Associate Pro...
Alirocumab Drugbank ID :
by wilson
DB09302. Description. :. Alirocumab. is a biophar...
Treatment of Blood Cholesterol
by daniella
to Reduce Atherosclerotic Cardiovascular . Risk in...
Putting Your Skills to the Test
by deborah
Which ONE of the following statements regarding th...
Multi -omics Multi -omics
by megan
Biomarkers (~13K). Genomic (~10K). Proteomic (~6K)...
A peptide that has successfully bound to PCSK9 is now able to block the low-density lipoprotein (LD
by madeline
Publication about . this. . research. : . Y. Zhan...
1 Lipoproteins Most lipids are transported in the blood as part of
by ashley
lipoproteins. particles whose structure includes:...
Supplements to help manage total cholesterol LDL and HDLRed Yeast Ric
by margaret
RECOMMENDED WITH CAUTION Evaluated BenefitsLowerin...
SocietyPositionStatementCanadianCardiovascularSocietyPositionStatement
by elizabeth
CanadianJournalofCardiology34(2018)1553 Receivedfo...
Copyright 2016 Wolters Kluwer Health Inc All rights reserved
by summer
C URRENT O PINION Identifyingfamilialhypercholeste...
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 73 NUMBER 1 J
by iris
CHRISTOPHER SIBLEY,MDDepartment of Cardiology,John...
ExecutiveSummary
by elina
FamilialHypercholesterolemia:Screening,diagnosis a...
THE MANAGEMENT OF DYSLIPIDEMIA Updated Version 20 150 2006
by ariel
VA/DoD Clinical Practice Guideline Introduction ...
CLINICAL PRACTICE
by mia
USTRALIAN FAMILY Vol. 37, No. 7, July 2008 ichard ...
The role of cholesteryl ester transfer protein TaqIB polymorphism in y
by sophie
Bilal Ilanbey Meral Kayikcioglu Ebru Demirel Sez...
6701 Carnegie Ave Suite 500 Cleveland OH 44103 p 8663589828
by gelbero
ApoE genotype can affect:Response to treatment wit...
In The Name Of God Dyslipidemia
by PinkPandaBear
/Lipid management in . Diabetes. Dr.Zahra. . davo...
Drugs Used in H yperlipidemia
by WonderWoman
By. Dr. . Sasan. . Zaeri. PharmD. , PhD. Introduc...
ODYSSEY FH I and II In FH I:
by Aquamarine
From baseline to 24 weeks, the change in . LDL-C: ...
Load More...